On Invalid Date, Clearpoint Neuro (NASDAQ: CLPT) reported Q4 2023 earnings per share (EPS) of -$0.18, up 0% year over year. Total Clearpoint Neuro earnings for the quarter were -$4.62 million. In the same quarter last year, Clearpoint Neuro's earnings per share (EPS) was -$0.18.
As of Q2 2024, Clearpoint Neuro's earnings has grown year over year. Clearpoint Neuro's earnings in the past year totalled -$22.09 million.
What is CLPT's earnings date?
Clearpoint Neuro's earnings date is Invalid Date. Add CLPT to your watchlist to be reminded of CLPT's next earnings announcement.
What was CLPT's revenue last quarter?
On Invalid Date, Clearpoint Neuro (NASDAQ: CLPT) reported Q4 2023 revenue of $6.81 million up 31.62% year over year. In the same quarter last year, Clearpoint Neuro's revenue was $5.17 million.
What was CLPT's revenue growth in the past year?
As of Q2 2024, Clearpoint Neuro's revenue has grown 16.56% year over year. This is 7.18 percentage points higher than the US Medical Devices industry revenue growth rate of 9.39%. Clearpoint Neuro's revenue in the past year totalled $23.96 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.